A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target
出版年份 2020 全文链接
标题
A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target
作者
关键词
-
出版物
Journal of Hematology & Oncology
Volume 13, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-09-21
DOI
10.1186/s13045-020-00959-2
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myeloma
- (2020) Lijie Xing et al. LEUKEMIA
- Increased HDAC Activity and c-MYC Expression Mediate Acquired Resistance to WEE1 Inhibition in Acute Leukemia
- (2020) Tamara B. Garcia et al. Frontiers in Oncology
- WEE1 inhibition synergizes with CHOP chemotherapy and radiation therapy through induction of premature mitotic entry and DNA damage in diffuse large B-cell lymphoma
- (2020) Mathilde R. W. de Jong et al. Therapeutic Advances in Hematology
- Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer
- (2020) Todd M. Pitts et al. Cancers
- Inhibiting Wee1 and ATR kinases produces tumor-selective synthetic lethality and suppresses metastasis
- (2019) Amirali B. Bukhari et al. JOURNAL OF CLINICAL INVESTIGATION
- Combined Aurora kinase A (AURKA) and WEE1 inhibition demonstrates synergistic antitumor effect in squamous cell carcinoma of the head and neck
- (2019) Jong Woo Lee et al. CLINICAL CANCER RESEARCH
- Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukaemia
- (2019) Hussain Mubarak Al-Aamri et al. BMC CANCER
- Differential activity of ATR and WEE1 inhibitors in a highly sensitive subpopulation of DLBCL linked to replication stress
- (2019) Lucy A. Young et al. CANCER RESEARCH
- Sulfur Mustard Analog Mechlorethamine (Bis(2-chloroethyl)methylamine) Modulates Cell Cycle Progression via the DNA Damage Response in Human Lung Epithelial A549 Cells
- (2019) Yi-Hua Jan et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Adavosertib with chemotherapy (CT) in patients (pts) with platinum-resistant ovarian cancer (PPROC): An open label, four-arm, phase II study.
- (2019) Kathleen N. Moore et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA damage response inhibitor combinations exert synergistic antitumor activity in aggressive B cell lymphomas
- (2019) Valentina Restelli et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of Wee1 sensitizes AML cells to ATR inhibitor VE-822-induced DNA damage and apoptosis
- (2019) Wenxiu Qi et al. BIOCHEMICAL PHARMACOLOGY
- Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy
- (2019) Yong Fang et al. CANCER CELL
- Effects of MCRS1 on proliferation, migration, invasion, and epithelial mesenchymal transition of gastric cancer cells by interacting with Pkmyt1 protein kinase
- (2019) Xin-Meng Wang et al. CELLULAR SIGNALLING
- Bromodomain and Extraterminal Domain Inhibition Synergizes with WEE1‐Inhibitor AZD1775 Effect by Impairing Non‐Homologous End Joining and Enhancing DNA Damage in Non‐Small Cell Lung Cancer
- (2019) Yuta Takashima et al. INTERNATIONAL JOURNAL OF CANCER
- Overexpressed PKMYT1 promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma
- (2019) Qingyi Zhang et al. Cancer Management and Research
- Sequential combination of bortezomib and WEE1 inhibitor, MK-1775, induced apoptosis in multiple myeloma cell lines
- (2019) Rebecca S.S. Barbosa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- DNA Damage Repair Interference By WEE1 Inhibition with AZD1775 Overcomes Combined Azacitidine and Venetoclax Resistance in Acute Myeloid Leukmeia (AML)
- (2019) Raoul Tibes et al. BLOOD
- Upregulation of Myt1 Promotes Acquired Resistance of Cancer Cells to Wee1 Inhibition
- (2019) Cody W. Lewis et al. CANCER RESEARCH
- The balance between mitotic death and mitotic slippage in acute leukemia: a new therapeutic window?
- (2019) Andrea Ghelli Luserna di Rorà et al. Journal of Hematology & Oncology
- PKMYT1: a forgotten member of the WEE1 family
- (2019) Christopher R. M. Asquith et al. NATURE REVIEWS DRUG DISCOVERY
- Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer
- (2019) Yoo-Young Lee et al. Scientific Reports
- Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia
- (2019) Ghelli Luserna Di Rorà et al. Cancers
- WEE1 Inhibition Enhances Anti-Apoptotic Dependency as a Result of Premature Mitotic Entry and DNA Damage
- (2019) Mathilde Rikje Willemijn de Jong et al. Cancers
- Systematic expression analysis of WEE family kinases reveals the importance of PKMYT1 in breast carcinogenesis
- (2019) Yu Liu et al. CELL PROLIFERATION
- Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine
- (2018) Siang-Boon Koh et al. CANCER RESEARCH
- The combination of the PARP inhibitor olaparib and the Wee1 inhibitor AZD1775 as a new therapeutic option for small cell lung cancer
- (2018) Alice Lallo et al. CLINICAL CANCER RESEARCH
- A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell Carcinoma
- (2018) Eduardo Méndez et al. CLINICAL CANCER RESEARCH
- Whole-Genome Expression Microarray Combined with Machine Learning to Identify Prognostic Biomarkers for High-Grade Glioma
- (2018) Chang Shu et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Increased activity of both CDK1 and CDK2 is necessary for the combinatorial activity of WEE1 inhibition and cytarabine
- (2018) Tamara B. Garcia et al. LEUKEMIA RESEARCH
- Proteomics Profiling of CLL Versus Healthy B-cells Identifies Putative Therapeutic Targets and a Subtype-independent Signature of Spliceosome Dysregulation
- (2018) Harvey E. Johnston et al. MOLECULAR & CELLULAR PROTEOMICS
- Targeting the replication stress response in cancer
- (2018) Josep V. Forment et al. PHARMACOLOGY & THERAPEUTICS
- Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach
- (2018) Mathilde R. W. de Jong et al. PLoS One
- ATR/CHK1 inhibitors and cancer therapy
- (2018) Zhaojun Qiu et al. RADIOTHERAPY AND ONCOLOGY
- Combined Inhibition of ATR and WEE1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
- (2018) Juan Jin et al. NEOPLASIA
- Nucleolar integrity during interphase supports faithful Cdk1 activation and mitotic entry
- (2018) Yuki Hayashi et al. Science Advances
- Combination of lutetium-177 labelled anti-L1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: a novel combination against human ovarian carcinoma
- (2018) Dennis Lindenblatt et al. BMC CANCER
- Strategic development of AZD1775, a Wee1 kinase inhibitor, for cancer therapy
- (2018) Siqing Fu et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The Role of Tumor Microenvironment in Chemoresistance: 3D Extracellular Matrices as Accomplices
- (2018) Dimakatso Senthebane et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
- (2018) Andrea Ghelli Luserna Di Rorà et al. Journal of Hematology & Oncology
- Premature activation of Cdk1 leads to mitotic events in S phase and embryonic lethality
- (2018) Radoslaw Szmyd et al. ONCOGENE
- Fighting tubulin-targeting anticancer drug toxicity and resistance
- (2017) Roberta Visconti et al. ENDOCRINE-RELATED CANCER
- PKMYT1 promoted the growth and motility of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling
- (2017) Lei Liu et al. EXPERIMENTAL CELL RESEARCH
- The cell cycle checkpoint inhibitors in the treatment of leukemias
- (2017) A. Ghelli Luserna di Rora’ et al. Journal of Hematology & Oncology
- Structural Basis of Wee Kinases Functionality and Inactivation by Diverse Small Molecule Inhibitors
- (2017) Jin-Yi Zhu et al. JOURNAL OF MEDICINAL CHEMISTRY
- PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP Inhibitors
- (2017) Leslie A. Parsels et al. MOLECULAR CANCER RESEARCH
- A Small-Molecule Inhibitor of WEE1, AZD1775, Synergizes with Olaparib by Impairing Homologous Recombination and Enhancing DNA Damage and Apoptosis in Acute Leukemia
- (2017) Tamara B. Garcia et al. MOLECULAR CANCER THERAPEUTICS
- CDK4/6 Inhibitors Sensitize Rb-positive Sarcoma Cells to Wee1 Kinase Inhibition through Reversible Cell-Cycle Arrest
- (2017) Ashleigh M. Francis et al. MOLECULAR CANCER THERAPEUTICS
- Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 Kinases
- (2017) et al. MOLECULES
- Suppression of Sirt1 sensitizes lung cancer cells to WEE1 inhibitor MK-1775-induced DNA damage and apoptosis
- (2017) G Chen et al. ONCOGENE
- Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest
- (2017) Navin Sarin et al. PLoS One
- Prolonged mitotic arrest induced by Wee1 inhibition sensitizes breast cancer cells to paclitaxel
- (2017) Cody W. Lewis et al. Oncotarget
- Mutational status of TP53 defines the efficacy of Wee1 inhibitor AZD1775 in KRAS-mutant non-small cell lung cancer
- (2017) Bo Mi Ku et al. Oncotarget
- Dietary polyphenols influence antimetabolite agents: methotrexate, 6-mercaptopurine and 5-fluorouracil in leukemia cell lines
- (2017) Amani Mahbub et al. Oncotarget
- Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway
- (2017) Santosh Kumar Singh et al. Oncotarget
- WEE1 inhibition targets cell cycle checkpoints for triple negative breast cancers to overcome cisplatin resistance
- (2017) Hongping Zheng et al. Scientific Reports
- Mechanisms responsible for the synergistic antileukemic interactions between ATR inhibition and cytarabine in acute myeloid leukemia cells
- (2017) Jun Ma et al. Scientific Reports
- Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulation
- (2016) Valentina Restelli et al. BRITISH JOURNAL OF HAEMATOLOGY
- Identification of clinically achievable combination therapies in childhood rhabdomyosarcoma
- (2016) Elliot Kahen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A Mechanism for Controlled Breakage of Under-replicated Chromosomes during Mitosis
- (2016) Heike Duda et al. DEVELOPMENTAL CELL
- Phase II Study of WEE1 Inhibitor AZD1775 Plus Carboplatin in Patients With TP53-Mutated Ovarian Cancer Refractory or Resistant to First-Line Therapy Within 3 Months
- (2016) Suzanne Leijen et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study Evaluating WEE1 Inhibitor AZD1775 As Monotherapy and in Combination With Gemcitabine, Cisplatin, or Carboplatin in Patients With Advanced Solid Tumors
- (2016) Suzanne Leijen et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression and prognostic value of the WEE1 kinase in gliomas
- (2016) Darija Music et al. JOURNAL OF NEURO-ONCOLOGY
- BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma
- (2016) E.M. Novak et al. MEDICAL HYPOTHESES
- ATM Expression Predicts Veliparib and Irinotecan Sensitivity in Gastric Cancer by Mediating P53-Independent Regulation of Cell Cycle and Apoptosis
- (2016) Vinod Vijay Subhash et al. MOLECULAR CANCER THERAPEUTICS
- PTEN enhances G2/M arrest in etoposide-treated MCF-7 cells through activation of the ATM pathway
- (2016) RUOPENG ZHANG et al. ONCOLOGY REPORTS
- Errata
- (2016) RADIATION RESEARCH
- Expression and clinical significance of Wee1 in colorectal cancer
- (2016) Eivind Valen Egeland et al. TUMOR BIOLOGY
- Targeting the WEE1 kinase as a molecular targeted therapy for gastric cancer
- (2016) Hye-Young Kim et al. Oncotarget
- WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner
- (2016) Shruti Lal et al. Scientific Reports
- Synergistic anti-leukemic interactions between panobinostat and MK-1775 in acute myeloid leukemia ex vivo
- (2015) Wenxiu Qi et al. CANCER BIOLOGY & THERAPY
- The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to antimicrotubule cancer drugs
- (2015) R Visconti et al. CELL DEATH AND DIFFERENTIATION
- Chk1 and Wee1 control genotoxic-stress induced G2–M arrest in melanoma cells
- (2015) Julio Vera et al. CELLULAR SIGNALLING
- Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors
- (2015) Khanh Do et al. JOURNAL OF CLINICAL ONCOLOGY
- Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736
- (2015) Valentina Restelli et al. Oncotarget
- AZD1775 sensitizes T cell acute lymphoblastic leukemia cells to cytarabine by promoting apoptosis over DNA repair
- (2015) James B. Ford et al. Oncotarget
- Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma
- (2015) Rosaria Chilà et al. Oncotarget
- Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1
- (2014) Lei Duan et al. CANCER BIOLOGY & THERAPY
- Re-purposing clinical kinase inhibitors to enhance chemosensitivity by overriding checkpoints
- (2014) Neil Beeharry et al. CELL CYCLE
- CHK It Out! Blocking WEE Kinase Routs TP53 Mutant Cancer
- (2014) J. E. Bauman et al. CLINICAL CANCER RESEARCH
- 988 Sequence Alterations in the WEE1 Non-Coding Region Is a Facilitator and Marker for Pancreatic Tumorigenesis
- (2014) Shruti Lal et al. GASTROENTEROLOGY
- Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions
- (2014) Ana Slipicevic et al. GYNECOLOGIC ONCOLOGY
- Habiterpenol, a novel abrogator of bleomycin-induced G2 arrest in Jurkat cells, produced by Phytohabitans suffuscus 3787_5
- (2014) Ryuji Uchida et al. JOURNAL OF ANTIBIOTICS
- Identification and Pharmacological Inactivation of the MYCN Gene Network as a Therapeutic Strategy for Neuroblastic Tumor Cells
- (2014) Olesya Chayka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CHK1 plays a critical role in the anti-leukemic activity of the wee1 inhibitor MK-1775 in acute myeloid leukemia cells
- (2014) Wenxiu Qi et al. Journal of Hematology & Oncology
- A regimen combining the Wee1 inhibitor AZD1775 with HDAC inhibitors targets human acute myeloid leukemia cells harboring various genetic mutations
- (2014) L Zhou et al. LEUKEMIA
- Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignancies
- (2014) E Weisberg et al. LEUKEMIA
- Computational analysis of image-based drug profiling predicts synergistic drug combinations: Applications in triple-negative breast cancer
- (2014) Miriam B. Brandl et al. Molecular Oncology
- WEE1 murine deficiency induces hyper-activation of APC/C and results in genomic instability and carcinogenesis
- (2014) A Vassilopoulos et al. ONCOGENE
- Targeting the wee1 kinase for treatment of pediatric Down syndrome acute myeloid leukemia
- (2014) J. Timothy Caldwell et al. PEDIATRIC BLOOD & CANCER
- Pemetrexed Induces S-Phase Arrest and Apoptosis via a Deregulated Activation of Akt Signaling Pathway
- (2014) Kun-Chieh Chen et al. PLoS One
- Vitamin C Effect on Mitoxantrone-Induced Cytotoxicity in Human Breast Cancer Cell Lines
- (2014) Eliana Guerriero et al. PLoS One
- Synergy of 1,25-dihydroxyvitamin D3 and carboplatin in growth suppression of SKOV-3 cells
- (2014) ZENGLI ZHANG et al. Oncology Letters
- CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo
- (2013) L. Chaudhuri et al. HAEMATOLOGICA
- Combination Drug Scheduling Defines a "Window of Opportunity" for Chemopotentiation of Gemcitabine by an Orally Bioavailable, Selective ChK1 Inhibitor, GNE-900
- (2013) E. Blackwood et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of Wee1 Sensitizes Cancer Cells to Antimetabolite Chemotherapeutics In Vitro and In Vivo, Independent of p53 Functionality
- (2013) A. A. Van Linden et al. MOLECULAR CANCER THERAPEUTICS
- Emerging landscape of oncogenic signatures across human cancers
- (2013) Giovanni Ciriello et al. NATURE GENETICS
- Targeting Wee1 for the treatment of pediatric high-grade gliomas
- (2013) Sabine Mueller et al. NEURO-ONCOLOGY
- Wee1 Inhibition by MK-1775 Leads to Tumor Inhibition and Enhances Efficacy of Gemcitabine in Human Sarcomas
- (2013) Jenny M. Kreahling et al. PLoS One
- RNAi screening of the kinome with cytarabine in leukemias
- (2012) R. Tibes et al. BLOOD
- The end of mitosis from a phosphatase perspective
- (2012) Roberta Visconti et al. CELL CYCLE
- Vincristine induces cell cycle arrest and apoptosis in SH-SY5Y human neuroblastoma cells
- (2012) YUE TU et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia
- (2012) C C Porter et al. LEUKEMIA
- WEE1 Kinase Inhibition Enhances the Radiation Response of Diffuse Intrinsic Pontine Gliomas
- (2012) V. Caretti et al. MOLECULAR CANCER THERAPEUTICS
- Structural and Spectroscopic Analysis of the Kinase Inhibitor Bosutinib and an Isomer of Bosutinib Binding to the Abl Tyrosine Kinase Domain
- (2012) Nicholas M. Levinson et al. PLoS One
- High Expression of Wee1 Is Associated with Poor Disease-Free Survival in Malignant Melanoma: Potential for Targeted Therapy
- (2012) Gry Irene Magnussen et al. PLoS One
- Fcp1-dependent dephosphorylation is required for M-phase-promoting factor inactivation at mitosis exit
- (2012) Roberta Visconti et al. Nature Communications
- Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1
- (2012) Marieke Aarts et al. Cancer Discovery
- WEE1 inhibition sensitizes osteosarcoma to radiotherapy
- (2011) Jantine PosthumaDeBoer et al. BMC CANCER
- Eukaryotic Origin-Dependent DNA Replication In Vitro Reveals Sequential Action of DDK and S-CDK Kinases
- (2011) Ryan C. Heller et al. CELL
- Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agent
- (2011) Diana Nguyen et al. CELL CYCLE
- MK-1775, a Potent Wee1 Inhibitor, Synergizes with Gemcitabine to Achieve Tumor Regressions, Selectively in p53-Deficient Pancreatic Cancer Xenografts
- (2011) N. V. Rajeshkumar et al. CLINICAL CANCER RESEARCH
- MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
- (2011) K. A. Bridges et al. CLINICAL CANCER RESEARCH
- Wee1 controls genomic stability during replication by regulating the Mus81-Eme1 endonuclease
- (2011) Raquel Domínguez-Kelly et al. JOURNAL OF CELL BIOLOGY
- Modulation of anthracycline-induced cytotoxicity by targeting the prenylated proteome in myeloid leukemia cells
- (2011) Michael A. Morgan et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Tyrosine kinase receptor inhibitor-targeted combined chemotherapy for metastatic bladder cancer
- (2011) Chia-Lun Wu et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Inhibitory Phosphorylation of Cyclin-Dependent Kinase 1 as a Compensatory Mechanism for Mitosis Exit
- (2011) J. P. H. Chow et al. MOLECULAR AND CELLULAR BIOLOGY
- Replication Stress Induces Micronuclei Comprising of Aggregated DNA Double-Strand Breaks
- (2011) Bing Xu et al. PLoS One
- Novel insights into maintaining genomic integrity: Wee1 regulating Mus81/Eme1
- (2011) Yusé Martín et al. Cell Division
- Cells expressing FLT3/ITD mutations exhibit elevated repair errors generated through alternative NHEJ pathways: implications for genomic instability and therapy
- (2010) J. Fan et al. BLOOD
- MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil
- (2010) Hiroshi Hirai et al. CANCER BIOLOGY & THERAPY
- In Silico Analysis of Kinase Expression Identifies WEE1 as a Gatekeeper against Mitotic Catastrophe in Glioblastoma
- (2010) Shahryar E. Mir et al. CANCER CELL
- Actinomycin D Decreases Mcl-1 Expression and Acts Synergistically with ABT-737 against Small Cell Lung Cancer Cell Lines
- (2010) H. Xu et al. CLINICAL CANCER RESEARCH
- How do Cdc7 and cyclin-dependent kinases trigger the initiation of chromosome replication in eukaryotic cells?
- (2010) K. Labib GENES & DEVELOPMENT
- Methotrexate, Paclitaxel, and Doxorubicin Radiosensitize HER2-Amplified Human Breast Cancer Cells to the Auger Electron-Emitting Radiotherapeutic Agent 111In-NLS-Trastuzumab
- (2010) D. L. Costantini et al. JOURNAL OF NUCLEAR MEDICINE
- Prophase I arrest and progression to metaphase I in mouse oocytes: comparison of resumption of meiosis and recovery from G2-arrest in somatic cells
- (2010) P. Solc et al. MOLECULAR HUMAN REPRODUCTION
- Myt1 protein kinase is essential for Golgi and ER assembly during mitotic exit
- (2008) Hiroyuki Nakajima et al. JOURNAL OF CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now